Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
medication use trajectories in myasthenia gravis pregnancies a population based drug utilization study
Original title: “Medication use trajectories in myasthenia gravis pregnancies: a population-based drug utilization study.”
non motor symptoms and healthcare utilization before diagnosis of myasthenia gravis a nationwide cohort study
Original title: “Non-motor symptoms and healthcare utilization before diagnosis of myasthenia gravis: a nationwide cohort study.”
management of exacerbations and rescue therapy a prespecified analysis of the phase 3 myasthenia gravis inebilizumab randomized clinical trial
Original title: “Management of Exacerbations and Rescue Therapy: A Prespecified Analysis of the Phase 3 Myasthenia Gravis Inebilizumab Randomized Clinical Trial.”
rate of autoimmune diseases in the 10 years preceding myasthenia gravis diagnosis a nationwide cohort study in south korea
Original title: “Rate of Autoimmune Diseases in the 10 Years Preceding Myasthenia Gravis Diagnosis: A Nationwide Cohort Study in South Korea.”
unusual sequential development of multiple sclerosis thymoma myasthenia and lymphoma in the same patient
Original title: “Unusual Sequential Development of Multiple Sclerosis, Thymoma, Myasthenia, and Lymphoma in the Same Patient.”
anti c2 mediated complement inhibition prevents disease in a rat passive transfer model of myasthenia gravis
Original title: “Anti-C2-mediated complement inhibition prevents disease in a rat passive transfer model of myasthenia gravis.”
refractory pembrolizumab induced myocarditis myositis myasthenia gravis overlap syndrome with concurrent hepatitis and thyroiditis in endometrial carcinoma a case report
Original title: “Refractory Pembrolizumab-Induced Myocarditis-Myositis-Myasthenia Gravis Overlap Syndrome With Concurrent Hepatitis and Thyroiditis in Endometrial Carcinoma: A Case Report.”
clinical effectiveness of efgartigimod in a broad population of patients with generalized myasthenia gravis subgroup analyses from a randomized double blind placebo controlled phase 3 trial adapt
Original title: “Clinical effectiveness of efgartigimod in a broad population of patients with generalized myasthenia gravis: subgroup analyses from a randomized, double‑blind, placebo‑controlled, phase 3 trial (ADAPT).”
current management and treatment of patients with myasthenia gravis in france a survey of the neurologist s perspective
Original title: “Current management and treatment of patients with myasthenia gravis in France: A survey of the neurologist's perspective.”
development of the first myasthenia gravis patient registry in latvia a single centre experience
Original title: “Development of the first myasthenia gravis patient registry in Latvia: a single-centre experience.”
alterations of blood immune subpopulations cytokines and metabolites in anti acetylcholine receptor antibody positive myasthenia gravis a real world observational high throughput study
Original title: “The alterations of blood immune subpopulations, cytokines, and metabolites in anti-acetylcholine receptor antibody-positive myasthenia gravis: a real-world, observational, high-throughput study.”
coexistence of parkinson s disease and myasthenia gravis with symptom exacerbation induced by biperiden a case report
Original title: “Coexistence of Parkinson's Disease and Myasthenia Gravis with Symptom Exacerbation Induced by Biperiden: A Case Report.”
correction to italian recommendations for the diagnosis and treatment of myasthenia gravis
Original title: “Correction to: Italian recommendations for the diagnosis and treatment of myasthenia gravis.”
evaluation of steroid toxicity using the glucocorticoid toxicity index metabolic domains instrument in adults with myasthenia gravis a real world study in the usa
Original title: “Evaluation of steroid toxicity using the Glucocorticoid Toxicity Index-Metabolic Domains instrument in adults with myasthenia gravis: a real-world study in the USA.”
healthcare professionals perspectives on barriers and facilitators in care and rehabilitation of adults with myasthenia gravis in neurological departments in denmark
Original title: “Healthcare Professionals' Perspectives on Barriers and Facilitators in Care and Rehabilitation of Adults with Myasthenia Gravis in Neurological Departments in Denmark.”
burden of disease in myasthenia gravis a targeted literature review
Original title: “Burden of Disease in Myasthenia Gravis: A Targeted Literature Review.”
This year’s American Academy of Neurology meeting included a presentation that could one day set a new treatment standard for myasthenia gravis.
Original title: “AAN 2026: J&J, Kyverna, Capricor and Praxis showcase practice-changing data”
insufficient immunosuppressive treatment in patients with myasthenia gravis in the context of the possibility of new therapies a single center experience
Original title: “Insufficient immunosuppressive treatment in patients with myasthenia gravis in the context of the possibility of new therapies - a single center experience.”
chimeric antigen receptor t cells in myasthenia gravis advances safety challenges and future directions
Original title: “Chimeric Antigen Receptor T-Cells in Myasthenia Gravis: Advances, Safety Challenges, and Future Directions.”
morvan syndrome in a patient with progressing metastatic thymoma and myasthenia gravis
Original title: “Morvan syndrome in a patient with progressing metastatic thymoma and myasthenia gravis.”